Phase I dose-escalation trial of a fructo-oligosaccharide (FOS) prebiotic in hematopoietic stem cell transplantation recipients
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP332103
下载链接
链接失效反馈官方服务：
资源简介：
DNA sequencing of stool samples from 31 hematopoietic stem cell transplantation recipients (15 cases/16 controls) enrolled in a phase I dose-escalation trial of a fructo-oligosaccharide (FOS) prebiotic. The primary study goal was to determine the tolerability of FOS as a microbiome targeted therapeutic. A secondary goal of the study was to characterize the gut microbiome of study participants
创建时间：
2021-08-15
